Chronic Recurrent Chilblains (Pernio, Investigational Adjunct)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for chilblains (perniosis). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for chronic recurrent chilblains is investigational.

Welche Evidenz existiert?

Tier C (investigational). Only anecdotal reports; there are no randomized controlled trials. Evidence-based therapy for chilblains: cold and moisture avoidance (strict), warm gloves and footwear, smoking cessation, and topical or oral nifedipine for refractory cases. Workup for underlying connective tissue disease (lupus, antiphospholipid syndrome, cryoglobulinemia, COVID-19 chilblain-like lesions) in atypical presentations.

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Worsening of cold sensitivity at the bite locations
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Trigger of severe vasospasm or new chilblain lesions
• Risk of tissue compromise in patients with peripheral arterial disease
• Delay of underlying connective tissue disease workup
• Permanent small scars at bite sites on cold-sensitive areas

Wer dies nicht in Betracht ziehen sollte

• Patients with active chilblain ulceration or open lesions
• Patients with suspected underlying lupus, antiphospholipid syndrome, or cryoglobulinemia (workup first)
• Patients with peripheral arterial disease (ABI <0.6) of the affected limb
• Patients with Raynaud's phenomenon with digital ulceration
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Patients who have not tried strict cold avoidance and topical nifedipine

Was Sie Ihren Kliniker fragen sollten

• Have I been worked up for connective tissue disease, antiphospholipid syndrome, or cryoglobulinemia?
• Have I tried strict cold avoidance and warm gloves/footwear?
• Am I a candidate for topical or oral nifedipine?
• Do I smoke, and have I been offered cessation support?
• Is my circulation normal (peripheral pulses, ABI)?
• What evidence specifically supports leech therapy for chilblains?
• What is the cost and is it covered by insurance? (typically not covered)

Wann dringende medizinische Versorgung suchen

• Sudden white, cold, or numb finger or toe that does not rewarm (possible critical limb ischemia)
• New ulceration or open sore at chilblain sites
• Spreading redness, warmth, pus, or red streaks (cellulitis)
• Fever above 38.0 C / 100.4 F or chills
• Bleeding from a bite site lasting more than 24 hours
• Hives, facial or tongue swelling, throat tightness, or breathing difficulty